We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA spelled out the conditions under which it will not take action when certain biological products are mixed, diluted, or repackaged in a manner not described in their approved labeling. Read More
The company previously paid $15.4 million to settle two whistleblower lawsuits alleging that Questcor bribed physicians to over-prescribe the gel. Read More